Abstract
Diagnostic and prognostic biomarkers are used to predict the progress and outcome of several chronic diseases, including neoplastic and noncommunicable diseases. Recently, biomarker research has been exploited to accurately discriminate the severe forms of malaria, since no biological tests to confirm the diagnosis of severe malaria and its complications are available so far. In this context, human lysozyme appears as a good candidate. Since its discovery almost one century ago, several easy-to-handle and cost-effective methods to determine lysozyme activity in various samples (plasma, urine, and tissue sections) have been developed. Interestingly, results from two small prospective studies enrolling healthy volunteers and malaria patients from Sudan showed a significant correlation between disease severity and lysozyme plasma levels. These promising data encourage further studies employing larger cohorts of patients from different areas endemic for malaria. Intriguingly, an old molecule such as human lysozyme might reveal itself as a new and effective biomarker for malaria severity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alderton G, Fevold HL (1946) Direct crystallization of lysozyme from egg white and some crystalline salts of lysozyme. J Biol Chem 164:1–5
Amodu OK, Adeyemo AA, Olumese PE et al (1997) Intraleucocyte malaria pigment in asymptomatic and uncomplicated malaria. East Afr Med J 74:714–716
Amodu OK, Adeyemo AA, Olumese PE et al (1998) Intraleucocytic malaria pigment and clinical severity of malaria in children. Trans R Soc Trop Med Hyg 92:54–56
Coca SG, Parikh CR (2008) Urinary biomarkers for acute kidney injury: perspectives on translation. Clin J Am Soc Nephrol 3:481–490
Dunn WB, Hardin JH, Spicer SS (1968) Ultrastructural localization of myeloperoxidase in human neutrophil and rabbit heterophil and eosinophil leucocytes. Blood 32:935–944
Falchuk KR, Perrotto JL, Isselbacher KJ (1975) Serum lysozyme in Crohn’s disease and ulcerative colitis. N Engl J Med 292:395–397
Fleming A (1922) On a remarkable bacteriolytic element found in tissues and secretions. Proc R Soc Lond Ser B Biol Sci 93:306–317
Ishii H, Iwata A, Oka H et al (2010) Elevated serum levels of lysozyme in desquamative interstitial pneumonia. Intern Med 49:847–851
Linnoila I, Petrusz P (1984) Immunohistochemical techniques and their applications in the histopathology of the respiratory system. Environ Health Perspect 56:131–148
Litwack G (1955) Photometric determination of lysozyme activity. Proc Soc Exp Biol Med 89:401–403
Lu D, Li Q, Wu Z et al (2014) High-level recombinant human lysozyme expressed in milk of transgenic pigs can inhibit the growth of Escherichia coli in the duodenum and influence intestinal morphology of sucking pigs. PLoS One 9:e89130
Lucchi NW, Jain V, Wilson NO et al (2011) Potential serological biomarkers of cerebral malaria. Dis Markers 31:327–335
Mohamed AO, Elbashir MI, Ibrahim G et al (1996) Neutrophil leucocyte activation in severe malaria. Trans R Soc Trop Med Hyg 90:277
Mohammed AO, Elghazali G, Mohammed HB et al (2003) Human neutrophil lipocalin: a specific marker for neutrophil activation in severe Plasmodium falciparum malaria. Acta Trop 87:279–285
Ogutu B, Tiono AB, Makanga M et al (2010) Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria? Malar J 9:30
Osserman EF, Lawlor DP (1966) Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med 124:921–952
Peeters TL, Vantrappen G, Geboes K (1976) Serum lysozyme levels in Crohn’s disease and ulcerative colitis. Gut 17:300–305
Peeters TL, Depraetere YR, Vantrappen GR (1978) Radioimmunoassay for urinary lysozyme in human serum from leukemic patients. Clin Chem 24:2155–2157
Pepe MS, Etzioni R, Feng Z et al (2001) Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93:1054–1061
Polimeni M, Valente E, Aldieri E et al (2012) Haemozoin induces early cytokine-mediated lysozyme release from human monocytes through p38 MAPK- and NF-kappaB-dependent mechanisms. PLoS One 7(6):e39497
Polimeni M, Valente E, Aldieri E et al (2013) Role of 15-hydroxyeicosatetraenoic acid in hemozoin-induced lysozyme release from human adherent monocytes. Biofactors 39(3):304–314
Prato M (2012) Human and mosquito lysozymes in malaria: old molecules for new approaches towards diagnosis, therapy and vector control. J Bacteriol Parasitol 3:e113
Prato M, Giribaldi G, Arese P (2009) Hemozoin triggers tumor necrosis factor alpha-mediated release of lysozyme by human adherent monocytes: new evidences on leucocyte degranulation in P. falciparum malaria. Asian Pac J Trop Med 2:35–40
Seal DV, Mackie IA, Coakes RL et al (1980) Quantitative tear lysozyme assay: a new technique for transporting specimens. Br J Ophthalmol 64:700–704
Smolelis AN, Hartsell SE (1949) The determination of lysozyme. J Bacteriol 58:731–736
Thomas MJ, Russo A, Craswell P et al (1981) Radioimmunoassay for serum and urinary lysozyme. Clin Chem 27:1223–1226
Tiwari S, Ali MJ, Balla MM et al (2012) Establishing human lacrimal gland cultures with secretory function. PLoS One 7:e29458
Were T, Davenport GC, Yamo EO et al (2009) Naturally acquired hemozoin by monocytes promotes suppression of RANTES in children with malarial anemia through an IL-10-dependent mechanism. Microbes Infect 11:811–819
Xu SY, Carlson M, Engström A et al (1994) Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand J Clin Lab Invest 54:365–376
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Prato, M., Polimeni, M., Tullio, V. (2015). Human Lysozyme in Malaria Patients: Possible Role as Biomarker for Disease Severity. In: Prato, M. (eds) Human and Mosquito Lysozymes. Springer, Cham. https://doi.org/10.1007/978-3-319-09432-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-09432-8_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09431-1
Online ISBN: 978-3-319-09432-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)